The mean serum TFF3 level in the patients with gastric cancer was 9.37 ± 4.67 ng/mL, which was significantly higher compared with that in the control group (7.05 ± 3.28 ng/mL; P < 0.001; Table 1, Figure 1). Here, TFF3 is linked to gastric cancer.